ARTICLE | Clinical News
EMA reviewing Aeterna Zentaris' Macrilen to evaluate AGHD
December 8, 2017 4:07 AM UTC
EMA accepted for review an MAA from Aeterna Zentaris Inc. (TSX:AEZS; NASDAQ:AEZS) for Macrilen macimorelin acetate (Macrimorelin-GHST, AEZS-130) to evaluate adult growth hormone deficiency (AGHD)...
BCIQ Company Profiles
BCIQ Target Profiles